https://www.ncbi.nlm.nih.gov/pmc/articles/PMC79961..

Watch

Events

Browse Events My events

Article

Browse articles

Market

Latest Products

Pages

My Pages Liked Pages

More

TTN Ads Forum Explore Popular Posts Jobs Offers Fundings Analytics

Ministries Events Article My Pages Analytics See all

3 yrs

https://www.ncbi.nlm.nih.gov/p....mc/articles/PMC79961

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

www.ncbi.nlm.nih.gov

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we have studied the possible mechanism of action of ivermectin using in silic

Like

Comment

Latest Products See all